These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 21598353)

  • 1. Each generation improves on the last (in cardiology): Bayesian thinking, the randomized clinical trial, and directed evolution.
    Morrison DA
    Catheter Cardiovasc Interv; 2011 Jun; 77(7):1018-9. PubMed ID: 21598353
    [No Abstract]   [Full Text] [Related]  

  • 2. To excel or to confirm? That is the question.
    Dangas G
    Catheter Cardiovasc Interv; 2011 Jun; 77(7):944. PubMed ID: 21598346
    [No Abstract]   [Full Text] [Related]  

  • 3. Left main and high-risk PCI: what, exactly, is it high risk for?
    Safian RD
    Catheter Cardiovasc Interv; 2011 Jun; 77(7):952-3. PubMed ID: 21598347
    [No Abstract]   [Full Text] [Related]  

  • 4. It's not the dye, but the "die" in dialysis: which coronary revascularization strategy really is best?
    Butman SM
    Catheter Cardiovasc Interv; 2010 Dec; 76(7):949-50. PubMed ID: 21108371
    [No Abstract]   [Full Text] [Related]  

  • 5. More openness and a little less strut: two good ideas for stents and the people who implant them.
    Morrison DA
    Catheter Cardiovasc Interv; 2010 Nov; 76(5):652-3. PubMed ID: 20976746
    [No Abstract]   [Full Text] [Related]  

  • 6. Another small step for small vessels.
    Morrison DA
    Catheter Cardiovasc Interv; 2010 Jul; 76(1):67-9. PubMed ID: 20578195
    [No Abstract]   [Full Text] [Related]  

  • 7. The fork in the road: a dedicated turn or a provisional one?
    Mehran R
    Catheter Cardiovasc Interv; 2011 May; 77(6):807-8. PubMed ID: 21520382
    [No Abstract]   [Full Text] [Related]  

  • 8. Drug-eluting stents: safe but not sufficient.
    Vogel RA
    JACC Cardiovasc Interv; 2009 Jun; 2(6):513-4. PubMed ID: 19539254
    [No Abstract]   [Full Text] [Related]  

  • 9. Drug-eluting stent implantation for the treatment of cardiac transplant vasculopathy: the jury is still out.
    Belardi JA
    Catheter Cardiovasc Interv; 2011 Jun; 77(7):970-1. PubMed ID: 21598349
    [No Abstract]   [Full Text] [Related]  

  • 10. DES in SVGs: safe and at least short-term effective.
    Hillegass WB
    Catheter Cardiovasc Interv; 2011 Feb; 77(3):356-7. PubMed ID: 21328680
    [No Abstract]   [Full Text] [Related]  

  • 11. Provisional side-branch stenting in distal left main lesions: one-size-may-not-fit-all.
    Belardi JA
    Catheter Cardiovasc Interv; 2011 May; 77(6):773-4. PubMed ID: 21520379
    [No Abstract]   [Full Text] [Related]  

  • 12. Optimizing the impact of primary percutaneous coronary intervention in acute myocardial infarction.
    Satler LF
    Catheter Cardiovasc Interv; 2011 Feb; 77(2):201. PubMed ID: 21290554
    [No Abstract]   [Full Text] [Related]  

  • 13. Validating the EXCEL hypothesis: a propensity score matched 3-year comparison of percutaneous coronary intervention versus coronary artery bypass graft in left main patients with SYNTAX score ≤32.
    Capodanno D; Caggegi A; Capranzano P; Cincotta G; Miano M; Barrano G; Monaco S; Calvo F; Tamburino C
    Catheter Cardiovasc Interv; 2011 Jun; 77(7):936-43. PubMed ID: 21547994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and efficacy of drug eluting stents compared with bare metal stents for saphenous vein graft interventions: a comprehensive meta-analysis of randomized trials and observational studies comprising 7,994 patients.
    Hakeem A; Helmy T; Munsif S; Bhatti S; Mazraeshahi R; Cilingiroglu M; Effat M; Leesar M; Arif I
    Catheter Cardiovasc Interv; 2011 Feb; 77(3):343-55. PubMed ID: 21328679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug eluting stents in CTOs: why not?
    Vetrovec GW
    Catheter Cardiovasc Interv; 2011 Feb; 77(3):333-4. PubMed ID: 21328678
    [No Abstract]   [Full Text] [Related]  

  • 16. The Gordian knot of revascularization for multivessel coronary artery disease.
    Takagi H; Manabe H; Umemoto T
    J Thorac Cardiovasc Surg; 2011 Jul; 142(1):241-2; author reply 242-3. PubMed ID: 21683848
    [No Abstract]   [Full Text] [Related]  

  • 17. Sirolimus- versus paclitaxel-eluting stents for unselected patients with coronary artery disease.
    Park SJ
    Catheter Cardiovasc Interv; 2011 Jan; 77(1):13-4. PubMed ID: 21181967
    [No Abstract]   [Full Text] [Related]  

  • 18. Four-year clinical follow-up of the XIENCE V everolimus-eluting coronary stent system in the treatment of patients with de novo coronary artery lesions: the SPIRIT II trial.
    Garg S; Serruys PW; Miquel-Hebert K;
    Catheter Cardiovasc Interv; 2011 Jun; 77(7):1012-7. PubMed ID: 20824770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravascular ultrasound optimization of drug-eluting stents: still not enough data.
    Leesar MA
    Catheter Cardiovasc Interv; 2010 Mar; 75(4):584-5. PubMed ID: 20333656
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparison of single- versus two-stent techniques in treatment of unprotected left main coronary bifurcation disease.
    Kim WJ; Kim YH; Park DW; Yun SC; Lee JY; Kang SJ; Lee SW; Lee CW; Park SW; Park SJ
    Catheter Cardiovasc Interv; 2011 May; 77(6):775-82. PubMed ID: 21520380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.